When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMPE - Ampio down 5% premarket after discontinuing patient enrollment in late-stage AP-013 trial amid COVID-19
Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals (NYSEMKT:AMPE) has suspended patient enrollment in its Phase 3 clinical trial of Ampion ("AP-013") for the treatment of severe osteoarthritis of the knee, due to the COVID-19 pandemic.
More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,